# K200429: BEE Cages

- Pathway: 510(k) (Traditional)
- Applicant: NGMedical GmbH
- Decided: Jan 29, 2021 after 343 days
- Product code: ODP (Intervertebral Fusion Device With Bone Graft, Cervical)
- Device class: 2
- Regulation: 21 CFR 888.3080
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 16 generations back to K841189 (1984). 118 ancestors in all.
11 later devices descend from it; 5 cite it directly.
1 of 130 devices in its family (counting itself) has a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K170503: EIT Cellular Titanium Cervical Cage, EIT Cellular Titanium PLIF Cages, EIT Cellular Titanium TLIF Cages, and EIT Cellular Titanium ALIF Cages, Eit Emerging Implant Technologies GmbH (2017) Summary page 4.

## Most influential descendants
- K222833: Ventana™ C Spinal System (2023), 4 descendants of its own
- K240416: Tranquil-C Interbody System (2024), 3 descendants of its own
- K241467: Stable-C Interbody System (2024), 2 descendants of its own
- K231252: Ventana™ L Spinal System (2023), 1 descendant of its own
- K211413: BEE PLIF Cage (2021), 1 descendant of its own

## Indications for use
BEE Cages are intended for intervertebral body fusion devices in skeletally mature patients for the treatment of cervical disc degeneration and/or cervical spinal instability as confirmed by imaging studies (radiographs, CT, MRI) that results in radiculopathy, myelopathy and/or pain at one or two contiguous levels from C2-T1. These patients should have had at least six weeks of nonoperative treatment. BEE Cages are to be used with autogenous and/or allogeneic bone graft comprised of cancellous and/or corticocancellous bone graft to facilitate fusion and in combination with supplemental fixation indicated for cervical fusion procedures.

Source page: https://510kreport.com/device/K200429
Methodology: https://510kreport.com/methodology